Thyroid disease post-COVID-19 infection: Report of a case with new-onset autoimmune thyroid disease

Thyroid disease post-COVID-19 infection: Report of a case with new-onset autoimmune thyroid disease

We present hyperthyroidism with autoimmune thyroid disease, which developed a few weeks after the COVID-19 infection in a patient with no prior thyroid disease. Our case was described with clinical presentations, diagnostic tests, and subsequent patient management and compared to other similar repor...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Asia Pacific allergy 2023-03, Vol.13 (1), p.54-56
Hauptverfasser: Trinh, Anh Ngoc, Nguyen, Kim Han, Nguyen, Dinh Van
Format: Artikel
Sprache:eng
Schlagworte:
Case Report
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 56
container_issue 1
container_start_page 54
container_title Asia Pacific allergy
container_volume 13
creator Trinh, Anh Ngoc
Nguyen, Kim Han
Nguyen, Dinh Van
description We present hyperthyroidism with autoimmune thyroid disease, which developed a few weeks after the COVID-19 infection in a patient with no prior thyroid disease. Our case was described with clinical presentations, diagnostic tests, and subsequent patient management and compared to other similar reported cases. A 28-year-old female patient with no prior history of thyroid dysfunction developed hyperthyroidism 8 weeks after COVID-19 infection, confirmed by low thyroid stimulating hormone, high free thyroxine 4, and thyroid receptor antibody. She was treated and responded well to methimazole 20 mg in a few weeks. We searched the literature and found three other similar reported cases and compared those. The effects of COVID-19 infection on the immune system and the thyroid gland might explain the pathology of hyperthyroidism post-COVID-19 infection in this patient. This new-onset hyperthyroidism was found in a woman with mild symptoms and responded well to thiamazole and β-blockers.
doi_str_mv 10.5415/apallergy.0000000000000023
format Article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10166241</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>37389097</sourcerecordid><originalsourceid>FETCH-LOGICAL-c394t-43d9f949d27c159e581066a3eb98cd193b65f382bd515143e9272e5a678011813</originalsourceid><addsrcrecordid>eNpdkF1LwzAUhoMobsz9BQnedzZJkya7EZlfg8FAprchTdMt0jUlyRz791qmxXluzoFz3ufAA8ANSic0Q_RWtaqujV8fJulJYXIGhhgTknDM-Hk_52wAxiF8dDcU85zhSzAgOeEiFfkQ6NXm4J0tYWmDUcHA1oWYzJbv84cECWibyuhoXTOFr6Z1PkJXQQV1d7m3cQMbs09cE0yEahed3W53jYHxlHkFLipVBzP-6SPw9vS4mr0ki-XzfHa_SDQRWUwyUopKZKLEuUZUGMpRypgiphBcl0iQgtGKcFyUFFGUESNwjg1VLOcpQhyREbg7cttdsTWlNk30qpatt1vlD9IpK083jd3ItfuUKEWM4awjTI8E7V0I3lR9GKWy0y97_fK__u_w9d_3ffRXNvkC6n6ECQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Thyroid disease post-COVID-19 infection: Report of a case with new-onset autoimmune thyroid disease</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>PubMed Central Open Access</source><creator>Trinh, Anh Ngoc ; Nguyen, Kim Han ; Nguyen, Dinh Van</creator><creatorcontrib>Trinh, Anh Ngoc ; Nguyen, Kim Han ; Nguyen, Dinh Van</creatorcontrib><description>We present hyperthyroidism with autoimmune thyroid disease, which developed a few weeks after the COVID-19 infection in a patient with no prior thyroid disease. Our case was described with clinical presentations, diagnostic tests, and subsequent patient management and compared to other similar reported cases. A 28-year-old female patient with no prior history of thyroid dysfunction developed hyperthyroidism 8 weeks after COVID-19 infection, confirmed by low thyroid stimulating hormone, high free thyroxine 4, and thyroid receptor antibody. She was treated and responded well to methimazole 20 mg in a few weeks. We searched the literature and found three other similar reported cases and compared those. The effects of COVID-19 infection on the immune system and the thyroid gland might explain the pathology of hyperthyroidism post-COVID-19 infection in this patient. This new-onset hyperthyroidism was found in a woman with mild symptoms and responded well to thiamazole and β-blockers.</description><identifier>ISSN: 2233-8276</identifier><identifier>EISSN: 2233-8268</identifier><identifier>DOI: 10.5415/apallergy.0000000000000023</identifier><identifier>PMID: 37389097</identifier><language>eng</language><publisher>Netherlands: Lippincott Williams &amp; Wilkins</publisher><subject>Case Report</subject><ispartof>Asia Pacific allergy, 2023-03, Vol.13 (1), p.54-56</ispartof><rights>Copyright © 2023. Asia Pacific Association of Allergy, Asthma and Clinical Immunology.</rights><rights>Copyright © 2023. Asia Pacific Association of Allergy, Asthma and Clinical Immunology. 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c394t-43d9f949d27c159e581066a3eb98cd193b65f382bd515143e9272e5a678011813</citedby><cites>FETCH-LOGICAL-c394t-43d9f949d27c159e581066a3eb98cd193b65f382bd515143e9272e5a678011813</cites><orcidid>0000-0001-9812-9539 ; 0000-0002-5675-0850</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166241/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166241/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37389097$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Trinh, Anh Ngoc</creatorcontrib><creatorcontrib>Nguyen, Kim Han</creatorcontrib><creatorcontrib>Nguyen, Dinh Van</creatorcontrib><title>Thyroid disease post-COVID-19 infection: Report of a case with new-onset autoimmune thyroid disease</title><title>Asia Pacific allergy</title><addtitle>Asia Pac Allergy</addtitle><description>We present hyperthyroidism with autoimmune thyroid disease, which developed a few weeks after the COVID-19 infection in a patient with no prior thyroid disease. Our case was described with clinical presentations, diagnostic tests, and subsequent patient management and compared to other similar reported cases. A 28-year-old female patient with no prior history of thyroid dysfunction developed hyperthyroidism 8 weeks after COVID-19 infection, confirmed by low thyroid stimulating hormone, high free thyroxine 4, and thyroid receptor antibody. She was treated and responded well to methimazole 20 mg in a few weeks. We searched the literature and found three other similar reported cases and compared those. The effects of COVID-19 infection on the immune system and the thyroid gland might explain the pathology of hyperthyroidism post-COVID-19 infection in this patient. This new-onset hyperthyroidism was found in a woman with mild symptoms and responded well to thiamazole and β-blockers.</description><subject>Case Report</subject><issn>2233-8276</issn><issn>2233-8268</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNpdkF1LwzAUhoMobsz9BQnedzZJkya7EZlfg8FAprchTdMt0jUlyRz791qmxXluzoFz3ufAA8ANSic0Q_RWtaqujV8fJulJYXIGhhgTknDM-Hk_52wAxiF8dDcU85zhSzAgOeEiFfkQ6NXm4J0tYWmDUcHA1oWYzJbv84cECWibyuhoXTOFr6Z1PkJXQQV1d7m3cQMbs09cE0yEahed3W53jYHxlHkFLipVBzP-6SPw9vS4mr0ki-XzfHa_SDQRWUwyUopKZKLEuUZUGMpRypgiphBcl0iQgtGKcFyUFFGUESNwjg1VLOcpQhyREbg7cttdsTWlNk30qpatt1vlD9IpK083jd3ItfuUKEWM4awjTI8E7V0I3lR9GKWy0y97_fK__u_w9d_3ffRXNvkC6n6ECQ</recordid><startdate>202303</startdate><enddate>202303</enddate><creator>Trinh, Anh Ngoc</creator><creator>Nguyen, Kim Han</creator><creator>Nguyen, Dinh Van</creator><general>Lippincott Williams &amp; Wilkins</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-9812-9539</orcidid><orcidid>https://orcid.org/0000-0002-5675-0850</orcidid></search><sort><creationdate>202303</creationdate><title>Thyroid disease post-COVID-19 infection: Report of a case with new-onset autoimmune thyroid disease</title><author>Trinh, Anh Ngoc ; Nguyen, Kim Han ; Nguyen, Dinh Van</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c394t-43d9f949d27c159e581066a3eb98cd193b65f382bd515143e9272e5a678011813</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Case Report</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Trinh, Anh Ngoc</creatorcontrib><creatorcontrib>Nguyen, Kim Han</creatorcontrib><creatorcontrib>Nguyen, Dinh Van</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Asia Pacific allergy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Trinh, Anh Ngoc</au><au>Nguyen, Kim Han</au><au>Nguyen, Dinh Van</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Thyroid disease post-COVID-19 infection: Report of a case with new-onset autoimmune thyroid disease</atitle><jtitle>Asia Pacific allergy</jtitle><addtitle>Asia Pac Allergy</addtitle><date>2023-03</date><risdate>2023</risdate><volume>13</volume><issue>1</issue><spage>54</spage><epage>56</epage><pages>54-56</pages><issn>2233-8276</issn><eissn>2233-8268</eissn><abstract>We present hyperthyroidism with autoimmune thyroid disease, which developed a few weeks after the COVID-19 infection in a patient with no prior thyroid disease. Our case was described with clinical presentations, diagnostic tests, and subsequent patient management and compared to other similar reported cases. A 28-year-old female patient with no prior history of thyroid dysfunction developed hyperthyroidism 8 weeks after COVID-19 infection, confirmed by low thyroid stimulating hormone, high free thyroxine 4, and thyroid receptor antibody. She was treated and responded well to methimazole 20 mg in a few weeks. We searched the literature and found three other similar reported cases and compared those. The effects of COVID-19 infection on the immune system and the thyroid gland might explain the pathology of hyperthyroidism post-COVID-19 infection in this patient. This new-onset hyperthyroidism was found in a woman with mild symptoms and responded well to thiamazole and β-blockers.</abstract><cop>Netherlands</cop><pub>Lippincott Williams &amp; Wilkins</pub><pmid>37389097</pmid><doi>10.5415/apallergy.0000000000000023</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0001-9812-9539</orcidid><orcidid>https://orcid.org/0000-0002-5675-0850</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2233-8276
ispartof Asia Pacific allergy, 2023-03, Vol.13 (1), p.54-56
issn 2233-8276
2233-8268
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10166241
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; PubMed Central Open Access
subjects Case Report
title Thyroid disease post-COVID-19 infection: Report of a case with new-onset autoimmune thyroid disease
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T06%3A12%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Thyroid%20disease%20post-COVID-19%20infection:%20Report%20of%20a%20case%20with%20new-onset%20autoimmune%20thyroid%20disease&rft.jtitle=Asia%20Pacific%20allergy&rft.au=Trinh,%20Anh%20Ngoc&rft.date=2023-03&rft.volume=13&rft.issue=1&rft.spage=54&rft.epage=56&rft.pages=54-56&rft.issn=2233-8276&rft.eissn=2233-8268&rft_id=info:doi/10.5415/apallergy.0000000000000023&rft_dat=%3Cpubmed_cross%3E37389097%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/37389097&rfr_iscdi=true